The effectiveness and value of emicizumab and valoctocogene roxaparvovec for the management of hemophilia A without inhibitors: A summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council
Agboola, Foluso, Rind, David M, Walton, Surrey M, Herron-Smith, Serina, Quach, Danny, Pearson, Steven D
Published in Journal of managed care & specialty pharmacy (01.05.2021)
Published in Journal of managed care & specialty pharmacy (01.05.2021)
Get full text
Journal Article
The effectiveness and value of emicizumab and valoctocogene roxaparvovec for the management of hemophilia A without inhibitors
Agboola, Foluso, Rind, David M, Walton, Surrey M, Herron-Smith, Serina, Quach, Danny, Pearson, Steven D
Published in Journal of managed care & specialty pharmacy (01.05.2021)
Published in Journal of managed care & specialty pharmacy (01.05.2021)
Get more information
Journal Article